Gold has been up around 14% in August, bullion given fresh impetus by the US Treasury's unexpected intervention in the bond market. Guy Wolf, Global Head of Market Analytics at Marex spoke to Bloomberg's Abeer Abu Omar on Horizons Middle East & Africa on the reason that is helping gold rise.
India's big AI bet is backed by government incentives and investments from global tech giants, and it's aiming to become a key hub in the AI economy. Bloomberg's Saritha Rai reports on whether it can translate this massive spending into a lasting advantage.
Former Reserve Bank of India Governor, Raghuram Rajan, says the US Federal Reserve should raise interest rates to contain accelerating inflation. Rajan, who is also serving on a task force set up to examine the US central bank, says he believes financial conditions are not restrictive at this point. He joined Bloomberg's Insight with Haslinda Amin from Jackson Hole, Wyoming.
Ann Prendergast, Head of EMEA and Interim Head of APAC at State Street Investment Management, discusses the investment opportunities in the ETF market. She speaks with Paul Allen on Bloomberg: The Asia Trade.
Darshan Hiranandani, Chairman and co-founder of Yotta Data Services, discusses the company's growth outlook, its transformation into an AI cloud firm amid rising demand, and its IPO plans. He speaks with Shery Ahn on Bloomberg Tech: Asia.
Hemant Mohapatra, Partner at Lightspeed India, discusses the investment opportunities in India's AI startup ecosystem. He speaks with Shery Ahn on Bloomberg Tech: Asia.
Padraig McDonnell, CEO of Agilent Technologies, discussed the company's recent financial performance following a quarter that saw approximately 7% organic revenue growth and an adjusted earnings per share (EPS) of $1.62. The conversation focused on the key drivers behind this growth and the factors contributing to the strong EPS figure. He speaks with Romaine Bostick & Emily Graffeo on "The Close."
Everpure reported a strong quarter with a 38% revenue increase and raised its full-year sales guidance to approximately $600 million. Chairman and CEO Charlie Giancarlo attributed growth to both higher prices and significant market share gains, including a 50% increase in core product sales and a 120% rise in its as-a-service offerings year over year. He speaks with Romaine Bostick & Emily Graffeo on "The Close."
Saira Malik, Chief Investment Officer at Nuveen, talks about what she wants to hear from Fed Chair Kevin Warsh in Jackson Hole and she explains why she's bullish on software stocks. Malik speaks on "Bloomberg The Close."
Revolution Medicines won US approval for a breakthrough pill that lengthens the lives of patients with advanced pancreatic cancer, a major advance against one of the hardest-to-treat tumor types. The once-daily drug carries a list price of more than $475,000 a year, making it one of the most expensive cancer treatments in history. The company branded it Rasonque and made it available starting Wednesday. It's one of the first medicines to broadly target RAS, a protein tied to tumor growth that's mutated in most pancreatic cancers. The approval opens a new front against a disease where treatment has advanced slowly. Bloomberg's Madison Muller reports.
Jack Manley, Global Market Strategist at JPMorgan Asset Management, said that he's not expecting to get any information about the path of rates from Fed Chair Kevin Warsh's remarks in Jackson Hole. Manley said that he expects Warsh to paint inflation as the 'be all, end all' for the Fed's economic policy decisions and potentially give insight into how he is measuring that data.
Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Emily Graffeo, Lisa Mateo and Tim Stenovec.
